SynthesisThoracic cancer2024

Efficacy of first-line immune checkpoint inhibitor and anti-angiogenic agent combination therapy for Kirsten rat sarcoma viral antigen-mutant advanced non-small-cell lung cancer: a systematic review and network meta-analysis.

Akinari Tsukada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.